Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism

British Journal of Pharmacology

Volumn 136, Issue 3, 2002, Pages 375-382

  Xu, Biao ^a,b   Xiao hong, Li ^a   Lin, Gao ^a   Queen, Lindsay ^b   Ferro, Albert ^b  

^a AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Amlodipine; Angiotensin converting enzyme; Bradykinin receptor; Calcium antagonists; HOE 140; Nifedipine; Nitric oxide; Vasorelaxation; Verapamil

Indexed keywords

AMLODIPINE; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VERAPAMIL; ACETYLCHOLINE; ANTIOXIDANT; ARGININE; ASCORBIC ACID; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; CALCIUM CHANNEL; CITRULLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HISTAMINE; ICATIBANT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; TRITIUM;

ANIMAL; ARTICLE; BLOOD; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; FEMORAL ARTERY; HUMAN; METABOLISM; PHYSIOLOGY; RABBIT; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY LIGATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN CELL; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL;

AMLODIPINE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMORAL ARTERY; HUMANS; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDYL-DIPEPTIDASE A; RABBITS; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; VASODILATION; VERAPAMIL; ANIMAL; COMPARATIVE STUDY; HUMAN; NITRIC-OXIDE SYNTHASE; SUPPORT, NON-U.S. GOV'T;

EID: 0036016107     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704753     Document Type: Article

References (31)

1. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans
2. Endothelium-dependent relaxation in resistance arteries from spontaneously hypertensive rats: Effect of long-term treatment with perindopril, quinapril, hydralazine or amlodipine
3. Bradykinin and inflammatory pain
4. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions
5. Agonistic and antagonistic properties of the bradykinin B2 receptor antagonist, HOE 140, in isolated blood vessels from different species
6. 2-adrenoceptors in human umbilical vein
7. 15N]nitrate in biological fluids
8. 1-adrenoreceptor antagonist monatepil maleate
9. Impact of a combination of a calcium antagonist and a beta-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and murine J774 cells
10. Protein measurement with the Folin phenol reagent
11. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
12. In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with α-tocopherol
13. Substance P precursor and kininogen: Their structures, gene organizations, and regulation
14. Calcium-channel blockers inhibit low-density lipoprotein oxidation by oxygen radicals
15. Nitric oxide and atherosclerosis
16. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
17. Nitric oxide activity in the human coronary circulation: Impact of risk factors for coronary atherosclerosis
18. NO metabolites accumulate in erythrocytes in proportion to carbon dioxide and bicarbonate concentration
19. Pharmacology of bradykinin and related kinins
20. Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein
21. Calcium antagonisis as inhibitors of in vitro low density lipoprotein oxidation and glycation
22. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension
23. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease
24. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production
25. 2-adrenergic stimulation or cyclic AMP elevation in vivo
26. Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis
27. Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent
28. Amlodipine promotes kinin-mediated nitric oxide production in coronary microvessels of failing human hearts
29. Paradoxical release of nitric oxide by an L-type calcium channel antagonist, the r+ enantiomer of amlodipine
30. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment of heart failure
31. Amlodipine enhances NO production induced by an ACE inhibitor through a kinin-mediated mechanism in canine coronary microvessels